Clinical Trials
8 trialsNCT06539468 2026-04-14
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
University of Michigan Rogel Cancer Center
Phase NA Recruiting
NCT00003641 2026-02-25
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
NCT07338968 2026-01-14
CoMpass
Aura Biosciences
Not yet recruiting
NCT02694965 2024-02-14
Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma
Duke University
Completed
NCT05898347 2023-06-12
Nevoid Basal Cell Carcinomas in Gorlin Syndrome
Oslo University Hospital
Unknown
NCT04625491 2021-02-10
Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor.
Hospital Universitario Virgen de la Arrixaca
Unknown
NCT03220009 2018-10-03
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00445952 2018-02-01
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Completed